Tacrolimus 1 mg/1 (Tacrolimus CAPSULE) 1 mg/1

Tacrolimus 1 mg capsules are an immunosuppressant medication used to prevent organ rejection. Learn about its uses, effects, and precautions for safe handling.

Strength

1 mg/1

Pack Size

100 CAPSULE in 1 BOTTLE, PLASTIC (0378-2046-01)

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tacrolimus 1 mg capsules are primarily used to prevent organ rejection in transplant patients. This medication works by suppressing the immune system to help the body accept the transplanted organ. It is often prescribed in combination with other immunosuppressants. Tacrolimus is also used for other conditions where immune system suppression is necessary, such as certain autoimmune disorders.

Side Effects

Common effects of Tacrolimus 1 mg capsules may include headaches, nausea, and tremors. Some users might experience increased blood pressure or kidney problems. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Tacrolimus 1 mg capsules should be handled with care and stored as directed. Avoid crushing or breaking the capsules. Always follow the prescribed dosage and administration instructions. Regular blood tests may be required to monitor kidney function and drug levels in the blood.

Avoid Interactions

Tacrolimus 1 mg capsules can interact with various medications, including certain antibiotics, antifungals, and heart medications. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Grapefruit juice and other CYP3A inhibitors can also affect the metabolism of Tacrolimus.

Frequently Asked Questions

Tacrolimus is primarily used to prevent organ rejection in transplant patients and to treat certain autoimmune disorders.

Tacrolimus 1 mg capsules should be stored at room temperature, away from moisture and heat.

Common side effects may include headaches, nausea, tremors, and increased blood pressure.

Tacrolimus can interact with various medications, so it is important to consult a healthcare provider before combining it with other drugs.

Long-term use of Tacrolimus requires regular monitoring by a healthcare provider to manage potential side effects and interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.